|
PRESS RELEASE
- FOR IMMEDIATE RELEASE 9AM EDT 08/19/2006
FDA approves Intralytix’s Food Safety Product
(LMP 102)
Baltimore, MD, August 19, 2006: Intralytix, Inc.
announced today that the Food and Drug Administration has
approved LMP 102 for use on ready-to-eat food. LMP 102 is a
bacteriophages based food safety product effective against
Listeria monocytogenes. LMP 102 is the first and only
bacteriophage-based product approved by FDA. Listeria
monocytogenes is the deadliest foodborne pathogen found in ready
to eat foods. “We are pleased with the approval by FDA of LMP
102. It is our intent to seek approval for additional food
safety products effective against E. coli O157:H7 and Salmonella
in the next 12 months” said John Vazzana, President and CEO of
Intralytix.
Intralytix (www.intralytix.com) is a
biotechnology company focused on the development of
bacteriophage-based products for the food safety, animal health
and human health markets. Intralytix is one of the world’s
leading companies in phage technology. Its offices and
laboratories are located in Baltimore, Maryland.
For more information, contact Dr. Alexander
Sulakvelidze at 410-625-2533,
or at asulakvelidze@intralytix.com.
|
